BRIEF—Aspire Pharma acquires Morningside generics companies

UK provider of niche generic and branded specialty pharmaceuticals Aspire Pharma says it has completed its acquisition of privately-held Morningside Pharmaceuticals (Loughborough), Morningside Healthcare (Leicester) and Morningside Healthcare (India).

No terms of the financial agreement were disclosed by either party.

Morningside is a provider of licensed prescription medicines to the UK’s National Health Service NHS and retail pharmacy sector, as well as international export markets.

The business has over 300 marketing authorizations in the UK and globally, covering a number of key therapeutic areas.

Morningside delivers Aspire added talent, increased in-market range, and an industry leading pipeline, complementary to Aspire’s.

The acquisition establishes Aspire as a premier speciality pharma organization in the UK, with new opportunities to support international growth ambitions.

The respective organizations will continue to operate as standalone businesses until further  integration and transition announcements are made.